Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Brits H., Adendorff J., Huisamen D., Beukes D., Botha K., Herbst H. et al. 2018 The prevalence of neonatal jaundice and risk factors in healthy term neonates at National District Hospital in Bloemfontein. Afr. J. Prim. Health Care Fam. Med. 10, 1582.
2. Capellini M. D. and Fiorelli G. 2008 Glucose-6-phosphate dehydrogenase deficiency. Lancet 371, 64–74.
3. Carvalho C. G., Castro S. M., Santin A. P., Zaleski C., Carvalho F. G. and Giugliani R. 2011 Glucose-6-phosphate-dehydrogenase deficiency and its correlation with other risk factors in jaundiced newborns in Southern Brazil. Asian Pac. J. Trop. Biomed. 1, 110–113.
4. Chaouch L., Said Y., Moumni I., Mahjoubi I., Chaabene A. B., Darragi I. et al. 2012 Implication of genetic variation at the promoter and exon 1 of UGT1A1 in occurrence of cholelithiasis in Tunisia. Ann. Biol. Clin. 70, 702–706.
5. Fertrin K. Y, Melo M. B, Assis A. M., Saad S. T. and Costa F. F. et al. 2003 UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin. Genet. 64, 160–162.